Bone Care, Genzyme deal

GENZ will acquire BCII for about $33 per share, or $719 million, in cash. The deal price is a 38% premium to BCII's close of $23.83 on Tuesday, before the deal was announced. Net of BCII's $119 million in cash, the deal value is $600 million. The acquisition is expected to close in the third quarter. ...